Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
1
x
$
30.00
Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
1
x
$
30.00
Use of Clozapine in the General Hospital (OPEN ACCESS)
1
x
$
0.00
The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
1
x
$
30.00
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
1
x
$
30.00
Treatment-Resistant Juvenile Depression—A Quicksand?
1
x
$
30.00
Amisulpride for Clozapine Induced Sialorrhea
1
x
$
30.00
Aliza P. Wingo - Frequency of Stimulant Treatment and of Stimulant-Associated Mania/Hypomania in Bipolar Disorder Patients
1
x
$
30.00
Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality
1
x
$
30.00
The Sex Effects Scale: Pilot Validation in a Healthy Population
1
x
$
30.00
Stellate Ganglion Blocks for Post-Traumatic Stress Disorder: A Review of Mechanisms, Efficacy, and Complications
1
x
$
30.00
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
1
x
$
30.00
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
The Black Book of Psychotropic Dosing and Monitoring
1
x
$
30.00
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
1
x
$
30.00
Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report
1
x
$
30.00
Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
1
x
$
30.00
Asenapine for the Control of Physical Aggression: A Prospective Naturalist Pilot Study
1
x
$
30.00
Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report
1
x
$
30.00
Salty Despair: An Adolescent’s Suicide Attempt through Salt Overdose
1
x
$
30.00
Catatonia and CPK Elevation in Neurosyphilis
1
x
$
30.00
Michael E. Thase, MD: Editor's Letter
1
x
$
0.00
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
1
x
$
30.00
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
1
x
$
30.00
Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist
1
x
$
30.00
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
1
x
$
30.00
Ken Gersing, MD: Predicting Antipsychotic Use in Children
1
x
$
30.00
Betty Jo Salmeron, MD: Pharmacological Applications of Magnetic Resonance Imaging
1
x
$
30.00
View Cart
Checkout
Home
Store
“Betty Jo Salmeron, MD: Pharmacological Applications of Magnetic Resonance Imaging” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-Resistant Schizophrenia
$
30.00
Add to cart
Details
Aripiprazole-induced Asymptomatic Hypertension: A Case Report
$
30.00
Add to cart
Details
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
$
30.00
Add to cart
Details
Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
$
30.00
Add to cart
Details
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
$
30.00
Add to cart
Details
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
$
30.00
Add to cart
Details
Table of Contents, Vol 47, No. 2, 2017
$
0.00
Add to cart
Details
Opium Withdrawal Delirium: Two Case Reports
$
30.00
Add to cart
Details
A Case of Olanzapine-Induced Fever
$
30.00
Add to cart
Details
Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report
$
30.00
Add to cart
Details
Treating an Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation
$
30.00
Add to cart
Details
Asenapine for the Control of Physical Aggression: A Prospective Naturalist Pilot Study
$
30.00
Add to cart
Details
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 1, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
New Single-Isomer Compounds on the Horizon
$
0.00
Add to cart
Details
Previous
1
…
14
15
16
…
44
Next
Page load link
Go to Top
